RecallCheckr

Imprimis NJOF, LLC recalls

9 recalls on record · FDA

Every recall we have on record for Imprimis NJOF, LLC, compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.

Filter:
Health Serious

Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular…

Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC Jan 14, 2026
Read the recall
Health Moderate

Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5%…

Sub-Potent Drug: Subpotent assay results during stability testing.

Imprimis NJOF, LLC Jul 30, 2025
Read the recall
Health Moderate

Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1%…

Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.

Imprimis NJOF, LLC Apr 9, 2025
Read the recall
Health Serious

Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL,…

Lack of Assurance of Sterility

Imprimis NJOF, LLC Jun 19, 2024
Read the recall
Health Serious

Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL),…

Lack of Assurance of Sterility

Imprimis NJOF, LLC Jun 5, 2024
Read the recall
Health Serious

Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular…

Lack of Assurance of Sterility

Imprimis NJOF, LLC Jun 5, 2024
Read the recall
Health Serious

Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular…

Lack of Assurance of Sterility

Imprimis NJOF, LLC Jun 5, 2024
Read the recall
Health Serious

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%,…

Subpotent Drug

Imprimis NJOF, LLC May 8, 2024
Read the recall
Health Moderate

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use…

Out of specification for assay

Imprimis NJOF, LLC May 8, 2024
Read the recall